Phase II trial using gemcitabine as monochemotherapy in patients with metastasized pancreatic cancer | springermedizin.at

Springer Medizin Österreich

nach oben

European Surgery

Erschienen in:

01.02.2004 | Invited Commentary

Phase II trial using gemcitabine as monochemotherapy in patients with metastasized pancreatic cancer

(Eur Surg 35: 337–341, 2003)

verfasst von: F. Kober, K. Glaser

Erschienen in: European Surgery | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Solitary cecal diverticulitis: report of a case

Nächster Artikel Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery

Titel: Phase II trial using gemcitabine as monochemotherapy in patients with metastasized pancreatic cancer
(Eur Surg 35: 337–341, 2003)
verfasst von: F. Kober
K. Glaser
Publikationsdatum: 01.02.2004
Verlag: Springer Vienna
Erschienen in: European Surgery / Ausgabe 1/2004
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-004-0023-5

Weitere Artikel der Ausgabe 1/2004

Editorial

Interdisciplinary trauma management and quality assessment at the Karl Franzens University Hospital, Graz

Invited Commentary

Interdisciplinary trauma management and quality assessment at the Karl Franzens University Hospital, Graz

Original Scientific Paper

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

Selected Commentary

The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients

Original Scientific Paper

Traumatic acromioclavicular joint separation – Current concepts

Main Topic